Cargando…

Effectiveness of Cell-Free and Concentrated Ascites Reinfusion Therapy in the Treatment of Malignancy-Related Ascites: A Systematic Review and Meta-Analysis

SIMPLE SUMMARY: Cell-free and concentrated ascites reinfusion therapy (CART) was a safe and effective palliative therapy in malignancy-related ascites. Abdominal distension, dyspnea, and fatigue were alleviated significantly after CART. The mean time to the next paracentesis was 20.7 days. In total,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Hao, Ishihara, Masashi, Horita, Nobuyuki, Tanzawa, Shigeru, Kazahari, Hiroki, Ochiai, Ryusuke, Sakamoto, Takahiko, Honda, Takeshi, Ichikawa, Yasuko, Watanabe, Kiyotaka, Seki, Nobuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508032/ https://www.ncbi.nlm.nih.gov/pubmed/34638357 http://dx.doi.org/10.3390/cancers13194873

Ejemplares similares

Effect of Adjuvant and Palliative Chemotherapy in Large Cell Neuroendocrine Carcinoma of the Lung: A Systematic Review and Meta-Analysis
por: Chen, Hao, et al.
Publicado: (2021)

Which is better, EGFR-TKI mono or combination for non-small cell lung cancer with mutated EGFR?
por: Tanzawa, Shigeru, et al.
Publicado: (2019)

Pretreatment neutrophil-to-lymphocyte ratio predicts treatment efficacy and prognosis of cytotoxic anticancer drugs, molecular targeted drugs, and immune checkpoint inhibitors in patients with advanced non-small cell lung cancer
por: Ishihara, Masashi, et al.
Publicado: (2021)

Ultrastructural observation of filtration membrane in cell‐free and concentrated ascites reinfusion therapy for malignant ascites
por: Koga, Kenichi, et al.
Publicado: (2021)

Weaning from concentrated ascites reinfusion therapy for refractory ascites by SGLT2 inhibitor
por: Miyamoto, Yasunori, et al.
Publicado: (2021)

Promising Combination Therapy with Bevacizumab and Erlotinib in an EGFR-Mutated NSCLC Patient with MET Amplification Who Showed Intrinsic Resistance to Initial EGFR-TKI Therapy
por: Seki, Nobuhiko, et al.
Publicado: (2019)

Need for Flexible Adjustment of the Treatment Schedule for Aprepitant Administration against Erlotinib-Induced Refractory Pruritus and Skin Rush
por: Seki, Nobuhiko, et al.
Publicado: (2019)

Feasibility of a fast-track randomized controlled trial of cell-free and concentrated ascites reinfusion therapy for patients with refractory malignant ascites
por: Yokomichi, Naosuke, et al.
Publicado: (2022)

Cell-free and Concentrated Ascites Reinfusion Therapy for Refractory Ascites in Cirrhosis in Post-marketing Surveillance and the Role of Tolvaptan
por: Iwasa, Motoh, et al.
Publicado: (2019)

A Case of Lung Adenocarcinoma with Marked Improvement of Pulmonary Lymphangitic Carcinomatosis by Adding Bevacizumab to Cisplatin and Pemetrexed
por: Natsume, Maika, et al.
Publicado: (2017)

A Case of Paraneoplastic Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Improved by Chemotherapy
por: Sakamoto, Takahiko, et al.
Publicado: (2017)

Reinfusion of ascites during hemodialysis as a treatment of massive refractory ascites and acute renal failure
por: Hsu, Ta-Wei, et al.
Publicado: (2011)

Cell-Free and Concentrated Ascites Reinfusion Therapy during Hemodialysis for Intradialytic Hypotension and Intractable Ascites
por: Hayasaka, Hideyuki, et al.
Publicado: (2022)

Successful Treatment with Taxane-Based Chemotherapy in Advanced Sebaceous Carcinoma: A Case Report and Literature Review
por: Ota, Shuji, et al.
Publicado: (2019)

A Patient with Advanced Gastric Cancer Who Achieved a Long-Term Prognosis by Early Diagnosis of Sister Mary Joseph's Nodule
por: Ota, Shuji, et al.
Publicado: (2018)

A Case of Advanced Submandibular Gland Cancer in Which Increased Prostate-Specific Antigen and Multiple Bone Metastases Wrongly Suggested Concurrent Prostate Cancer
por: Fukasawa, Yoko, et al.
Publicado: (2017)

Paraneoplastic IgA Vasculitis in an Adult with Lung Adenocarcinoma
por: Ota, Shuji, et al.
Publicado: (2017)

Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in refractory ascites: Post-marketing surveillance results
por: Hanafusa, Norio, et al.
Publicado: (2017)

Ascites reinfusion dialysis of refractory ascites as a bridge to kidney and liver transplantation in a patient on hemodialysis
por: Chang, Kyung Yoon, et al.
Publicado: (2017)

Significance of Earlier Initiation of Chemotherapy for Lung Cancer Complicated with Primary or Secondary Nephrotic Syndrome following Its Appropriate Differential Diagnosis
por: Ota, Shuji, et al.
Publicado: (2019)

Importance and Difficulty of Differentiating BMA-induced AFF Prodromal Symptoms from Hormonal Therapy-related Femoral Pain
por: Ota, Shuji, et al.
Publicado: (2019)

Adverse effects of cell-free and concentrated ascites reinfusion therapy for malignant ascites: a single-institute experience
por: Tsubokura, Misato, et al.
Publicado: (2022)

Proliferative Glomerulonephritis with Monoclonal IgG Deposits and Refractory Ascites: Successful Treatment with Rituximab and Cell-free and Concentrated Ascites Reinfusion Therapy
por: Takami, Norito, et al.
Publicado: (2022)

Cell-free and concentrated ascites reinfusion therapy for refractory massive cardiac ascites in an adult with single ventricle haemodynamics: a case report
por: Tsukishiro, Yasue, et al.
Publicado: (2023)

Development of a novel automatic ascites filtration and concentration equipment with multi‐ring‐type roller pump units for cell‐free and concentrated ascites reinfusion therapy
por: Okahisa, Toshiya, et al.
Publicado: (2020)

A Case of Cell-Free and Concentrated Ascites Reinfusion Therapy Effective for Refractory Ascites in Spontaneous Bacterial Peritonitis in a Renal Transplant Patient
por: Maeda, Atsuhiro, et al.
Publicado: (2012)

Verification of serum albumin elevating effect of cell-free and concentrated ascites reinfusion therapy for ascites patients: a retrospective controlled cohort study
por: Yamada, Yosuke, et al.
Publicado: (2019)

Ascites management by cell-free concentrated ascites reinfusion therapy during recovery from drug-induced acute liver injury: a case report
por: Yasuda, Koya, et al.
Publicado: (2020)

Encapsulating peritoneal sclerosis caused by cell-free and concentrated ascites reinfusion therapy: a case report
por: Itagaki, Hideya, et al.
Publicado: (2021)

Eradication of intractable malignant ascites by abdominocentesis, reinfusion of concentrated ascites, and adoptive immunotherapy with dendritic cells and activated killer cells in a patient with recurrent lung cancer: a case report
por: Kimura, Hideki, et al.
Publicado: (2008)

Chylous ascites in colorectal surgery: A systematic review
por: Ng, Zi Qin, et al.
Publicado: (2021)

Is Low Volume Drainage of Ascites Associated With Improved Survival in Digestive System Cancer Patients With Malignant Ascites?—A Retrospective Cohort Study
por: Hoshino, Shunya, et al.
Publicado: (2023)

Successful treatment of systemic AL amyloidosis with autologous hematopoietic stem cell transplantation combined with cell‐free and concentrated ascites reinfusion therapy
por: Oka, Satoko, et al.
Publicado: (2023)

Ascitic Fluid Analysis in the Differential Diagnosis of Ascites: Focus on Cirrhotic Ascites
por: Huang, Lin-Lin, et al.
Publicado: (2014)

Ascites, refractory ascites and hyponatremia in cirrhosis
por: Fortune, Brett, et al.
Publicado: (2017)

Comment on ‘Ascitic Fluid Analysis in the Differential Diagnosis of Ascites: Focus on Cirrhotic Ascites’
por: Ahmed, Furqan
Publicado: (2017)

Evaluation of the performance, operability, and safety of Plasauto μ, a new type of machine for cell‐free and concentrated ascites reinfusion therapy, in a postmarketing clinical study
por: Hasegawa, Midori, et al.
Publicado: (2021)

Ascites
Publicado: (1854)

Ascites—V: The Differential Diagnosis of the Cause of Ascites
Publicado: (1909)

Ascites Index – an attempt to objectify the assessment of ascites
por: Szkodziak, Piotr, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_i7ub9v11bo9otjb35dtn6j9j4g